Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsAt CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.
At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.
Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.
Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD
TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD
1.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
2.
ALK-positive lung cancer trial results show unprecedented progression-free survival.
3.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
3D Mammography Improves Long-Term Cancer Risk Prediction
1.
Menstrual-Cycle Effects on Cancer Drug Response
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Strategic Standards in Hematology for Specialists
4.
Remote Hematology Follow-Up: Advancements, Clinical Implications, and Future Directions
5.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
5.
Recognizing Symptoms That May Require Cancer Evaluation
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge